NasdaqCM - Delayed Quote USD
Capricor Therapeutics, Inc. (CAPR)
11.78
-2.16
(-15.49%)
At close: June 13 at 4:00:01 PM EDT
12.00
+0.22
+(1.87%)
After hours: June 13 at 7:59:23 PM EDT
Insider Roster
Insider roster data is derived solely from the last 24 months of Form 3 & Form 4 SEC filings.
| Individual or Entity | Most Recent Transaction | Date | Shares Owned as of Transaction Date |
|---|---|---|---|
| AUWAERTER PAUL GISBERT Director | Purchase | Oct 6, 2023 | 5,000 |
| BERGMANN ANTHONY Chief Financial Officer | Conversion of Exercise of derivative security | Mar 3, 2025 | 8,223 |
| COLLIER EARL M JR Director | Conversion of Exercise of derivative security | Feb 27, 2025 | 57,606 |
| DUNBAR GEORGE W JR Director | Conversion of Exercise of derivative security | Mar 3, 2025 | 11,306 |
| KRASNEY KAREN General Counsel | Conversion of Exercise of derivative security | Dec 13, 2024 | 28,047 |
| LITVACK FRANK I Director | Conversion of Exercise of derivative security | Mar 3, 2025 | 176,117 |
| MARBAN LINDA Chief Executive Officer | Conversion of Exercise of derivative security | Mar 3, 2025 | 211,104 |
| MUSKET DAVID B Director | Conversion of Exercise of derivative security | Aug 7, 2024 | 88,788 |
| NIPPON SHINYAKU CO., LTD. Beneficial Owner of more than 10% of a Class of Security | Purchase | Sep 20, 2024 | 7,090,350 |
Related Tickers
URGN UroGen Pharma Ltd.
12.03
+8.57%
KALV KalVista Pharmaceuticals, Inc.
12.96
-0.99%
NUVB Nuvation Bio Inc.
1.7300
-4.42%
RNA Avidity Biosciences, Inc.
31.37
-2.40%
CADL Candel Therapeutics, Inc.
5.13
-4.29%
SRPT Sarepta Therapeutics, Inc.
36.18
-3.03%
AXSM Axsome Therapeutics, Inc.
104.10
-2.02%
VRNA Verona Pharma plc
92.20
-0.32%
RGNX REGENXBIO Inc.
9.27
-9.12%
CLDX Celldex Therapeutics, Inc.
21.26
+4.47%